Chandra Bhagat Pharma share price
Extreme risk
You have to be logged in to add this to Watchlist.- ₹62.60(0.00%)March 12, 2025 15:40:03 PM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 12.70 K
Chandra Bhagat Pharma is trading -% upper at Rs 62.60 as compared to its last closing price. Chandra Bhagat Pharma has given -4.67% in this year & 7.93% in the last 5 days. Chandra Bhagat Pharma has TTM P/E ratio 34.42 as compared to the sector P/E of 23.69.The company posted a net profit of 0.68 Crores in its last quarter.Listed peers of Chandra Bhagat Pharma include Gujarat Terce Laboratories (7.03%), Sandu Pharmaceuticals (1.46%), Chandra Bhagat Pharma (-%).The Mutual Fund holding in Chandra Bhagat Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Chandra Bhagat Pharma was at 0.48% in 30 Sep 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Key Metrics
Updated on Mar 18, 2025, 10:51 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.63The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values29.83Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.10Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.57The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Chandra Bhagat Pharma Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in September quarter by 46.63% from Rs 64.92 crore to Rs 44.27 crore, year-on-year
- The company has grown its September quarter profit by 85.78% from Rs 0.37 crore to Rs 0.68 crore, year-on-year
The debt to equity of the company is higher than the industry median- Earnings are insufficient to cover the interest expenses on outstanding debt
Chandra Bhagat Pharma Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 70.80
- R2
- 74.65
- R3
- 82.35
Pivot63.10
- S1
- 59.25
- S2
- 51.55
- S3
- 47.70
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Chandra Bhagat Pharma Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Gujarat Terce Laboratories | Neutral | 70.80 | 7.03 | 52.54 | 211.94 | 7.26 | - | 13.05 |
| Sandu Pharmaceuticals | Bearish | 50.75 | 1.46 | 49.03 | 34.45 | 1.24 | 1.54 | 0.15 |
| Chandra Bhagat Pharma | Bearish | 62.60 | - | 47.23 | 29.74 | 1.63 | - | 4.87 |
| Deccan Health Care | Bearish | 17.10 | -6.04 | 38.33 | 24.49 | 0.41 | - | 1.73 |
| Roopa Industries | Bearish | 55.51 | 1.82 | 46.29 | 28.93 | 2.84 | - | 34.12 |
Chandra Bhagat Pharma Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Chandra Bhagat Pharma is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 69.29%
- Promoter(s) have increased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.85 percentage points from previous quarter
- Mutual Funds are not invested in this company.
Chandra Bhagat Pharma Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2024-11-13 | Half Yearly Results |
| 2024-05-30 | Audited Results |
| 2023-11-09 | Half Yearly Results |
| 2023-05-22 | Audited Results |
| 2022-11-14 | Half Yearly Results |
About the company Chandra Bhagat Pharma
- IndustryBiotechnology & Drugs
- ISININE07QQ01016
- BSE Code542934
- NSE Code
Chandra Bhagat Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care centers for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.
Chandra Bhagat Pharma Share Price FAQs
Chandra Bhagat Pharma is trading at 62.60 as on Wed Mar 12 2025 10:10:03. This is -% upper as compared to its previous closing price of 62.60.
The market capitalization of Chandra Bhagat Pharma is 47.23 Cr as on Wed Mar 12 2025 10:10:03.
The 52 wk high for Chandra Bhagat Pharma is 124.25 whereas the 52 wk low is 55.40
Chandra Bhagat Pharma can be analyzed on the following key metrics -
- TTM P/E: 34.42
- Sector P/E: 23.69
- Dividend Yield: 0.00%
- D/E ratio: 0.76
Chandra Bhagat Pharma reported a net profit of 1.53 Cr in 2024.
Quick Links